Pilot Study of Behavioural Intervention for Nutrition in Cystic Fibrosis

NCT ID: NCT01957072

Last Updated: 2015-03-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

17 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-02-28

Study Completion Date

2014-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Cystic Fibrosis (CF) is a lifelong condition which causes the lungs and digestive system to become clogged with thick, sticky mucus. This leads to recurrent lung infections and reduced nutrients absorption from food. The average age at death is 26 years, usually from respiratory failure. Nonetheless, the nutritional status of people with CF (PWCF) is important help them live healthier and longer.

It is recommended that adult with CF achieve a BMI of 23 for males and 22 for females. However, fewer than 50% adult with CF achieved that target BMI despite effective nutritional support to help support weight gain. There is a clear need for a behavioural intervention that can help PWCF use the available nutritional support.

This is a feasibility study to try out a multi-component behavioural intervention. The intervention is designed to help PWCF use their nutritional support to gain weight. It will focus on testing the methods and procedures to be used on a larger scale, improving the behavioural intervention and estimating the how many people are needed for the larger trial.

All eligible 75 PWCF in Sheffield will be invited to participate. The investigators anticipate recruiting 30 participants. Participants will be divided into two groups. The first group receive the behavioural intervention immediately. The second group receive the intervention after 3 months. All participants will be followed up for 6 months. Data will be collected every 6 weeks during clinic reviews.

These two groups will be compared against each other to estimate the potential impact of the behavioural intervention. The investigators will also interview some of the participants at the end of the study period to improve the intervention and the study processes based on participant feedback.

The investigators hypothesised that this study will recruit around 30 participants, around 80% of the participants will complete the study, a single full-time investigator can deliver the intervention to 15 participants over 3 months and data collection will be thorough (with less than 5% missing data). The investigators also hypothesised that this feasibility study will help improve the intervention and help the design of a larger trial.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cystic Fibrosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Behaviour change intervention

Intensive behaviour change intervention for 3 months, followed by a maintenance phase for 3 months

Group Type EXPERIMENTAL

Behaviour change intervention

Intervention Type BEHAVIORAL

The behaviour change intervention consists of

1. feedback via a web-based food diary
2. 'coaching' with problem-solving and implementation plans

The intensive intervention phase consists of 2 home visits, 8 telephone calls and 6 reminder emails.

The maintenance phase consists of 3 telephone calls and 4 reminder emails.

Wait-list Control

Usual care for 3 months, followed by intensive behaviour change intervention for 3 months

Group Type OTHER

Behaviour change intervention

Intervention Type BEHAVIORAL

The behaviour change intervention consists of

1. feedback via a web-based food diary
2. 'coaching' with problem-solving and implementation plans

The intensive intervention phase consists of 2 home visits, 8 telephone calls and 6 reminder emails.

The maintenance phase consists of 3 telephone calls and 4 reminder emails.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Behaviour change intervention

The behaviour change intervention consists of

1. feedback via a web-based food diary
2. 'coaching' with problem-solving and implementation plans

The intensive intervention phase consists of 2 home visits, 8 telephone calls and 6 reminder emails.

The maintenance phase consists of 3 telephone calls and 4 reminder emails.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* adult people with CF looked after at the Sheffield Adult CF Unit
* best BMI of \< 23 for males and \< 22 for females between Oct '12 and Oct '13

Exclusion Criteria

* patients in the palliative phase of disease
* patients who are pregnant
* patients who have no capacity to consent to participate in the study
* patients who have no IT facilities to use the web-based food diary
* patients who are unable to communicate by telephone for coaching
Minimum Eligible Age

16 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Sheffield Teaching Hospitals NHS Foundation Trust

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Martin J Wildman, PhD

Role: PRINCIPAL_INVESTIGATOR

Sheffield Teaching Hospitals NHS Foundation Trust

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Northern General Hospital, Sheffield Teaching Hospitals NHS Foundation Trust

Sheffield, South Yorkshire, United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United Kingdom

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

IRAS Project ID 139047

Identifier Type: OTHER

Identifier Source: secondary_id

STH17327

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

A CFit Study - Acute Exercise
NCT03237767 TERMINATED NA
Do More, B'More, Live Fit
NCT03109912 COMPLETED NA
CF Wellness Program
NCT07071324 NOT_YET_RECRUITING NA